These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25542975)

  • 1. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus.
    Cheng KW; Cheng SC; Chen WY; Lin MH; Chuang SJ; Cheng IH; Sun CY; Chou CY
    Antiviral Res; 2015 Mar; 115():9-16. PubMed ID: 25542975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.
    Lin MH; Moses DC; Hsieh CH; Cheng SC; Chen YH; Sun CY; Chou CY
    Antiviral Res; 2018 Feb; 150():155-163. PubMed ID: 29289665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme.
    Chen X; Chou CY; Chang GG
    Antivir Chem Chemother; 2009; 19(4):151-6. PubMed ID: 19374142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus.
    Chou CY; Chien CH; Han YS; Prebanda MT; Hsieh HP; Turk B; Chang GG; Chen X
    Biochem Pharmacol; 2008 Apr; 75(8):1601-9. PubMed ID: 18313035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional characterization of MERS coronavirus papain-like protease.
    Lin MH; Chuang SJ; Chen CC; Cheng SC; Cheng KW; Lin CH; Sun CY; Chou CY
    J Biomed Sci; 2014 Jun; 21(1):54. PubMed ID: 24898546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
    Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
    ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.
    Tomar S; Johnston ML; St John SE; Osswald HL; Nyalapatla PR; Paul LN; Ghosh AK; Denison MR; Mesecar AD
    J Biol Chem; 2015 Aug; 290(32):19403-22. PubMed ID: 26055715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
    Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
    J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structurally Guided Removal of DeISGylase Biochemical Activity from Papain-Like Protease Originating from Middle East Respiratory Syndrome Coronavirus.
    Daczkowski CM; Goodwin OY; Dzimianski JV; Farhat JJ; Pegan SD
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
    Bailey-Elkin BA; Knaap RC; Johnson GG; Dalebout TJ; Ninaber DK; van Kasteren PB; Bredenbeek PJ; Snijder EJ; Kikkert M; Mark BL
    J Biol Chem; 2014 Dec; 289(50):34667-82. PubMed ID: 25320088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV.
    Park JY; Ko JA; Kim DW; Kim YM; Kwon HJ; Jeong HJ; Kim CY; Park KH; Lee WS; Ryu YB
    J Enzyme Inhib Med Chem; 2016; 31(1):23-30. PubMed ID: 25683083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors.
    Kumar V; Tan KP; Wang YM; Lin SW; Liang PH
    Bioorg Med Chem; 2016 Jul; 24(13):3035-3042. PubMed ID: 27240464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling of the bat HKU4 coronavirus 3CL
    Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features.
    Lei J; Mesters JR; Drosten C; Anemüller S; Ma Q; Hilgenfeld R
    Antiviral Res; 2014 Sep; 109():72-82. PubMed ID: 24992731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.